Education
About Us
Working with TipRanks
Follow Us
Shanghai Pharmaceuticals Holding Co Class H (HK:2607)
:2607
RESEARCH TOOLSreports
Earnings Data
Report Date
Sep 02, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.44Last Year’s EPS
0.41Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Shanghai Pharmaceuticals Holding Co (HK:2607) Earnings, Revenues Date & History
HK:2607 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:2607 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2025 | HK$10.66 | HK$10.60 | -0.56% |
Mar 28, 2025 | HK$11.66 | HK$11.26 | -3.43% |
Oct 29, 2024 | HK$12.58 | HK$12.44 | -1.11% |
Aug 27, 2024 | HK$11.06 | HK$11.18 | +1.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Shanghai Pharmaceuticals Holding Co Class H (HK:2607) report earnings?
Shanghai Pharmaceuticals Holding Co Class H (HK:2607) is schdueled to report earning on Sep 02, 2025, TBA Not Confirmed.
What is Shanghai Pharmaceuticals Holding Co Class H (HK:2607) earnings time?
Shanghai Pharmaceuticals Holding Co Class H (HK:2607) earnings time is at Sep 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Shanghai Pharmaceuticals Holding Co Class H stock?
The P/E ratio of Shanghai Pharmaceuticals Holding Co is N/A.
What is HK:2607 EPS forecast?
HK:2607 EPS forecast for the fiscal quarter 2025 (Q2) is 0.44.